
US biotech firm Alynlam has elected Pfizer’s former executive VP and general counsel Amy Schulman to its board of directors. …

A leading big pharma figurehead who was to be instrumental in Pfizer’s future plans has stepped down unexpectedly. Amy Schulman …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

